Table 3 Overall survival
R/R AML receiving combination therapy N = 67 | |
|---|---|
Overall survival | |
Median overall survival, all patients, months (range) [95% CI] | 12.9 (0.1-55.3)a [95% CI 8.7–19.3] |
Median overall survival, CR/CRh responder, months (range) [95% CI] | 30.6 (11–55.3) [95% CI 19.3-NR] |
OS Probability All Patients, % (95% CI) | |
12 months | 53 (40-64) |
24 months | 33 (21-46) |
OS Probability CR/CRh responder, % (95% CI) | |
12 months | 90 (67-98) |
24 months | 73 (46-88) |